Windlas Biotech Ltd.

518.80 +8.10 ▲1.6%

21 February 2024, 04:12:32 PM
Volume: 92,932

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.windlasbiotech.com
Market Cap 1,076.64 Cr.
Enterprise Value(EV) 1,051.45 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 25.31 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 20.45 Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 207.35 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.50 Calculated using Price: 517.65
Dividend Yield 0.77 Period Ending 2023-03
No. of Shares Subscribed 2.08 Cr. 20,798,575 Shares
FaceValue 5
About Windlas Biotech Ltd.
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.

Windlas Biotech Ltd. Delivery

Delivered Qty
Traded Qty

Windlas Biotech Ltd. Performance

1 Day
+1.59%
1 Week
+5.01%
1 Month
+8.82%
3 Month
+18.56%
6 Month
+29.44%
1 Year
+103.13%
2 Year
+96.33%
5 Year
10 Year

Windlas Biotech Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.07 40.92 11.74 7.7 12.87 10.76
Return on Capital Employed (%) 14.54 40.49 15.05 9.93 14.88 14.39
Return on Assets (%) 3.83 22.01 7.45 4.97 9.7 8.39

Windlas Biotech Ltd. Balance Sheet

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 125 194 210 199 395 402 416
Non Curr. Liab. 21 8 3 4 0 3 3
Curr. Liab. 143 96 125 93 94 121 149
Minority Int.
Equity & Liab. 289 298 338 296 489 527 568
Non Curr. Assets 145 177 170 102 107 173 180
Curr. Assets 144 120 168 194 382 354 388
Misc. Exp. not W/O
Total Assets 289 298 338 296 489 527 568

Windlas Biotech Ltd. Profit and Loss

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 352 307 329 428 466 513 600
Other Income 4 4 2 3 7 10 11
Total Income 356 312 331 431 473 523 612
Total Expenditure -313 -269 -287 -373 -414 -453 -528
PBIDT 44 43 44 58 59 70 84
Interest -6 -5 -3 -1 -1 -1 -1
Depreciation -17 -11 -9 -13 -12 -12 -13
Taxation -9 -12 -8 -6 -7 -14 -17
Exceptional Items 50 -22
PAT 11 65 24 16 38 43 53
Minority Interest 0
Share Associate 0 -1 -7 0
Other Related Items
Consolidated Net Profit 11 64 16 16 38 43 53
Adjusted EPS 20 35 25 9 17 20 25

Windlas Biotech Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 35 19 25 11 9 61
Cash Fr. Inv. -11 -5 -14 -20 -155 -14
Cash Fr. Finan. -26 -6 -5 1 130 -44
Net Change -2 7 5 -8 -15 3
Cash & Cash Eqvt 7 13 18 16 1 4

Windlas Biotech Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 59.95 59.95 59.95 59.95 60.75 62.38 62.82 62.82 62.82
Public 40.05 40.05 40.05 40.05 39.25 37.62 37.18 37.18 37.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Windlas Biotech Ltd. Announcements

Tue, 20 Feb 2024
Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited has informed the Exchange about Schedule of meet
Tue, 20 Feb 2024
Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited has informed the Exchange about Schedule of meet
Fri, 16 Feb 2024
Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited has informed the Exchange about Transcript

Windlas Biotech Ltd. Technical Scans

Wed, 21 Feb 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Windlas Biotech Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 370,313.36 1,543.40 +0.3%
Cipla Ltd. 116,866.14 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. 105,898.11 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. 97,179.74 6,760.15 +0.0%
Divi's Laboratories Ltd. 96,854.88 3,649.10 -1.7%
Zydus Lifesciences Ltd. 90,440.44 893.80 -0.2%
Torrent Pharmaceuticals Ltd. 88,043.20 2,603.00 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.58 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 31.52 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.12 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 70.03 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.41 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,603.00 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.94 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 4.51 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.39 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.65 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,603.00 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,603.00 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,603.00 -1.6%

Windlas Biotech Ltd. FAQ's

What is Windlas Biotech share price?

Can I buy Windlas Biotech shares now?

What is the Dividend Yield of Windlas Biotech?

What is the Market Cap of Windlas Biotech?

What are the key metrics to analyse Windlas Biotech?

What is the 52 Week High and Low of Windlas Biotech?

What is the trend of Windlas Biotech share price?